Skip to content
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
December 2017

Breaking the Access Deadlock to Leave No One Behind


A contribution by EURORDIS and its members on possibilities for patients’ full and equitable access to rare disease therapies in Europe

EURORDIS Position Paper Breaking the Access Deadlock

This position paper is a contribution from EURORDIS and its members that offers a synthesis of their analysis, reflections and perspectives on the issue of access to rare disease therapies.

The position paper sets out a new four-pillar approach to tackling the challenges that prevent patients’ access to care and medicines, as well as the ambition to have 3 to 5 times more new rare disease therapies approved per year by 2025, 3 to 5 times cheaper than today.

In the paper, EURORDIS calls for a new model based on a collective conversation involving all stakeholders (patients, the pharmaceutical industry, national competent authorities, national health ministries, researchers, scientists and the European Medicines Agency).

This site is registered on wpml.org as a development site.